Karyopharm Therapeutics Inc. (KPTIQ) stock

KPTIQPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30

Share price

Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Karyopharm Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Karyopharm Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Karyopharm Therapeutics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on Feb 26, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing